Contraception
Volume 75, Issue 5 , Pages 367-371, May 2007

Safety and acceptability with the use of a contraceptive vaginal ring after surgical or medical abortion

Planned Parenthood of Houston and Southeast Texas Inc., Houston, TX 77004, USA

Received 3 July 2006; received in revised form 2 January 2007; accepted 9 January 2007. published online 12 March 2007.

Abstract 

Objective

The study was conducted to determine if a contraceptive vaginal ring (CVR) is a safe and acceptable method of contraception when used in the proximate postabortion period following first-trimester surgical or medical abortion.

Methods

A CVR was inserted within 1 week following a medical or surgical abortion. Participants were followed up for 3 months to determine safety and acceptability. Safety was measured by the absence of signs of infection or serious adverse events. Acceptability was assessed by the CVR satisfaction survey, completed at the 3-month follow-up visit.

Results

Of 81 participants enrolled in the study, 69 (85%) completed the first-month follow-up visit, and 54 (67%) completed the final 3-month follow-up visit. There were no serious adverse events and no signs of infection on physical exam. Most adverse events were mild and not specifically related to the CVR. Related adverse events were those commonly associated with hormonal contraception use. Eighty-nine percent of participants chose to continue the CVR as their birth control method.

Conclusion

The CVR is potentially safe and has high acceptability when used in the proximate postabortion period following a first-trimester abortion.

Keywords: Contraceptive vaginal ring, Abortion, Postabortion infection, Safety, Acceptability

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was an investigator-initiated study supported by an unrestricted educational grant from Organon USA Inc, Roseland, NJ, USA.

PII: S0010-7824(07)00068-6

doi:10.1016/j.contraception.2007.01.009

Contraception
Volume 75, Issue 5 , Pages 367-371, May 2007